Absci Corp (ABSI)
5.17
+0.09
(+1.77%)
USD |
NASDAQ |
May 06, 10:11
Absci Price to Book Value: 3.310 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 3.252 |
| May 02, 2024 | 3.188 |
| May 01, 2024 | 3.322 |
| April 30, 2024 | 3.034 |
| April 29, 2024 | 3.060 |
| April 26, 2024 | 2.932 |
| April 25, 2024 | 2.852 |
| April 24, 2024 | 2.90 |
| April 23, 2024 | 3.015 |
| April 22, 2024 | 2.887 |
| April 19, 2024 | 3.054 |
| April 18, 2024 | 3.182 |
| April 17, 2024 | 3.387 |
| April 16, 2024 | 3.444 |
| April 15, 2024 | 3.476 |
| April 12, 2024 | 3.732 |
| April 11, 2024 | 3.896 |
| April 10, 2024 | 3.892 |
| April 09, 2024 | 4.216 |
| April 08, 2024 | 3.611 |
| April 05, 2024 | 3.675 |
| April 04, 2024 | 3.579 |
| April 03, 2024 | 3.399 |
| April 02, 2024 | 3.290 |
| April 01, 2024 | 3.591 |
| Date | Value |
|---|---|
| March 28, 2024 | 3.636 |
| March 27, 2024 | 3.547 |
| March 26, 2024 | 3.335 |
| March 25, 2024 | 3.239 |
| March 22, 2024 | 3.169 |
| March 21, 2024 | 3.380 |
| March 20, 2024 | 3.258 |
| March 19, 2024 | 3.079 |
| March 18, 2024 | 2.983 |
| March 15, 2024 | 3.137 |
| March 14, 2024 | 3.066 |
| March 13, 2024 | 3.124 |
| March 12, 2024 | 3.162 |
| March 11, 2024 | 3.009 |
| March 08, 2024 | 3.214 |
| March 07, 2024 | 3.284 |
| March 06, 2024 | 3.431 |
| March 05, 2024 | 3.348 |
| March 04, 2024 | 3.654 |
| March 01, 2024 | 3.476 |
| February 29, 2024 | 2.726 |
| February 28, 2024 | 2.478 |
| February 27, 2024 | 2.600 |
| February 26, 2024 | 2.589 |
| February 23, 2024 | 2.478 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4262
Minimum
May 16 2023
4.302
Maximum
Nov 08 2021
1.442
Average
0.9988
Median
Oct 19 2022
Price to Book Value Benchmarks
| Amgen Inc | 32.26 |
| Creative Medical Technology Holdings Inc | 0.5587 |
| CytomX Therapeutics Inc | -- |
| HOOKIPA Pharma Inc | 1.009 |
| Recursion Pharmaceuticals Inc | 4.587 |
Price to Book Value Related Metrics
| PS Ratio | 83.21 |
| PEG Ratio | -1.249 |
| Price | 5.17 |
| Earnings Yield | -23.21% |
| Market Cap | 583.10M |
| PEGY Ratio | -1.249 |